Breast Cancer Clinical Trial

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Summary

The goal of this study is to access whether treatment of early state estrogen-rich breast cancers with neoadjuvant endocrine therapy will result in higher rates of margin negativity on lumpectomy specimen.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologically confirmed invasive breast cancer, clinically stage I-II.
Clinically lymph node negative
Eligible for anti-endocrine treatment (per medical oncologist)
Postmenopausal women
Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

Progesterone receptor negativity
High grade tumor
Synchronous non-breast malignancy
Receiving any other investigational agents that could impact the efficacy of this trial regimen
History of allergic reactions attributed to compounds of similar chemical or biologic composition to Anastrozole, Letrozole, Exemestane, Tamoxifen or other agents used in study
Uncontrolled intercurrent illness
Medical, psychiatric or other condition and/or social situations that would limit compliance with study requirements

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

70

Study ID:

NCT05150652

Recruitment Status:

Recruiting

Sponsor:

Emily Marcinkowski

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Kentucky Markey Cancer Center
Lexington Kentucky, 40536, United States More Info
Emily Marcinkowski, MD
Contact
859-257-4490
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

70

Study ID:

NCT05150652

Recruitment Status:

Recruiting

Sponsor:


Emily Marcinkowski

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.